Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

DD

Top Discussions Among DuPont de Nemours Investors Today

DuPont de Nemours logged a 1.1% change during today's afternoon session, and is now trading at a price of $74.57 per share.

DuPont de Nemours returned losses of -8.1% last year, with its stock price reaching a high of $90.06 and a low of $53.77. Over the same period, the stock underperformed the S&P 500 index by -22.2%. AThe company's 50-day average price was $71.93. DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. Based in Wilmington, DE, the Large-Cap Industrials company has 24,000 full time employees. DuPont de Nemours has offered a 2.1% dividend yield over the last 12 months.

EPS Growth Achieved Primarily Through Stock Repurchases:

2019 2020 2021 2022 2023 2024
Revenue (M) $15,436 $14,338 $12,566 $13,017 $12,068 $12,386
Operating Margins -1% -9% 11% 11% 4% 10%
Net Margins 4% -20% 51% 45% 4% 6%
Net Income (M) $600 -$2,923 $6,467 $5,868 $423 $703
Net Interest Expense (M) $667 $672 $525 $492 $396 $366
Depreciation & Amort. (M) $3,195 $3,094 $1,112 $1,135 $1,147 $599
Diluted Shares (M) 7,463 736 544 499 451 421
Earnings Per Share $0.67 -$4.01 $11.89 $11.75 $0.94 $1.67
EPS Growth n/a -698.51% 396.51% -1.18% -92.0% 77.66%
Avg. Price $79.02 $50.61 $73.69 $69.04 $76.93 $74.59
P/E Ratio 117.94 -12.62 6.18 5.87 81.84 44.4
Free Cash Flow (M) -$1,089 $1,029 $1,493 -$74 n/a $1,742
CAPEX (M) $2,472 $272 $788 $662 $619 $579
EV / EBITDA 63.23 27.51 18.96 15.42 24.63 21.39
Total Debt (M) $17,436 $15,612 $10,782 $8,074 $7,800 $9,018
Net Debt / EBITDA 5.18 7.12 3.45 1.71 3.28 4.0
Current Ratio 1.2 2.37 2.9 3.02 2.43 1.33

DuPont de Nemours has declining revenues and decreasing reinvestment in the business, good EPS growth resulting mainly from stock repurchases, and a highly leveraged balance sheet. On the other hand, the company has positive cash flows working in its favor. Furthermore, DuPont de Nemours has weak operating margins with a positive growth rate and just enough current assets to cover current liabilities, as shown by its current ratio of 1.33.

a Lower P/B Ratio Than Its Sector Average but Priced Beyond Its Margin of Safety:

DuPont de Nemours has a trailing twelve month P/E ratio of 423.1, compared to an average of 24.03 for the Industrials sector. Based on its EPS guidance of $4.39, the company has a forward P/E ratio of 16.4. DuPont de Nemours's PEG ratio is 24.97 on the basis of the 16.9% weighted average of the company and the broader market's EPS compound average growth rates. This suggests that the company's shares are overvalued. In contrast, the market is likely undervaluing DuPont de Nemours in terms of its equity because its P/B ratio is 1.35 while the sector average is 2.89. The company's shares are currently trading 63.3% below their Graham number.

DuPont de Nemours Has an Analyst Consensus of Some Upside Potential:

The 16 analysts following DuPont de Nemours have set target prices ranging from $47.0 to $113.0 per share, for an average of $88.62 with a buy rating. The company is trading -15.9% away from its average target price, indicating that there is an analyst consensus of some upside potential.

DuPont de Nemours has a very low short interest because 1.2% of the company's shares are sold short. Institutions own 74.5% of the company's shares, and the insider ownership rate stands at 0.21%, suggesting a small amount of insider investors. The largest shareholder is Vanguard Group Inc, whose 11% stake in the company is worth $3,554,321,094.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS